InventionMed S.A. (WSE:INM)
Poland
· Delayed Price · Currency is PLN 0.1774
-0.0008 (-0.45%)
At close: Mar 28, 2025
InventionMed Revenue
In the year 2024, InventionMed had annual revenue of 277.76K PLN with 45,810.74% growth. InventionMed had revenue of 115.44K in the quarter ending December 31, 2024.
Revenue
277.76K
Revenue Growth
+45,810.74%
P/S Ratio
134.04
Revenue / Employee
39.68K
Employees
7
Market Cap
37.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 277.76K | 277.16K | 45,810.74% |
| Dec 31, 2023 | 605.00 | -3.46K | -85.12% |
| Dec 31, 2022 | 4.07K | -6.39K | -61.10% |
| Dec 31, 2021 | 10.45K | 5.25K | 100.96% |
| Dec 31, 2020 | 5.20K | -35.80K | -87.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.61B |
| Synektik Spólka Akcyjna | 556.63M |
| Voxel | 492.41M |
| Celon Pharma | 209.54M |
| Selvita | 345.76M |
| Ryvu Therapeutics | 101.96M |
| Centrum Medyczne ENEL-MED | 680.32M |
| Scope Fluidics | 119.00K |